Fumaric Acid

Fumaric Acid

SCHEMBL5874539

CN(C)C.CN(C)C.O=C(O)C=CC(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.69
TP53 P04637 1/20 0.69
EGLN1 Q9GZT9 1/20 0.69
EGLN3 Q9H6Z9 1/20 0.69
HCAR2 Q8TDS4 5/20 0.50
ALDH1A1 P00352 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL5875144 1.00 TSHR (0.69) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL5874523 1.00 TSHR (0.69) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL5875151 1.00 TSHR (0.69) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL5874530 1.00 TSHR (0.69) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL5874534 1.00 TSHR (0.69) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL30625964 0.96 TSHR (0.64) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL4926762 0.96 TSHR (0.64) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL29087113 0.88
Maleic Acid SCHEMBL28218264 0.87 TSHR (0.53) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL28080369 0.87 TSHR (0.53) TSHRTP53EGLN1EGLN3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118064880-A Corrosion-resistant chemical nickel plating solution and preparation method thereof 德星化工(苏州)有限公司 2024-05-24 CN claimed
CN-119462685-A Arteannuin derivative and application thereof in treating cerebral apoplexy 上海英诺富成生物科技有限公司 2025-02-18 CN disclosed
CN-116814236-B Reservoir reforming fluid for tight oil reservoir and pressure flooding integrated yield increasing method 四川申和新材料科技有限公司 2025-02-14 CN disclosed
CN-118064880-A Corrosion-resistant chemical nickel plating solution and preparation method thereof 德星化工(苏州)有限公司 2024-05-24 CN disclosed
CN-117223076-A Electrochemical device and method for manufacturing the same 松下知识产权经营株式会社 2023-12-12 CN disclosed
CN-116814236-A Reservoir reforming fluid for tight oil reservoir and pressure flooding integrated yield increasing method 四川申和新材料科技有限公司 2023-09-29 CN disclosed
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2020-06-11 US disclosed
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-08-08 US disclosed
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
US-RE45994-E1 Electrolytic capacitor and its manufacturing method PANASONIC CORPORATION (JP) 2016-05-03 US disclosed
EP-0938108-B1 Electrolytic capacitor and its manufacturing method PANASONIC CORP (JP) 2015-04-08 EP disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-6962612-B1 Solid organic conductor is organic conductive polymer polymerized and bonded to surface of positive electrode; good impedance, small current leak, reliable, high dielectric strength. MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-11-08 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
US-6307735-B1 Electrolytic capacitor and its manufacturing method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2001-10-23 US disclosed
EP-0938108-A2 Electrolytic capacitor and its manufacturing method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1999-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, S100A10 TSHR 3146/4885TP53 2105/4885EGLN1 3325/4885
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, SRRM2, IK TSHR 1850/4885TP53 2548/4885EGLN1 2769/4885
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CD44, PCNA TSHR 3345/4885TP53 1209/4885EGLN1 2838/4885
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, DSG1 TSHR 2235/4885TP53 1442/4885EGLN1 3892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.